MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2

Abstract

This study demonstrates that miR-25-3p promotes proliferation by targeting tumor suppressor BTG2 and may identify new diagnostic and therapeutic targets in TNBC.